Loading clinical trials...
Loading clinical trials...
U.S./Canada Sarcoma Intergroup Study of OSI-774 in Malignant Peripheral Nerve Sheath Tumors, Phase II
Conditions
Interventions
erlotinib hydrochloride
Locations
101
United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
University of California Davis Cancer Center
Davis, California, United States
Contra Costa Regional Medical Center
Martinez, California, United States
St. Anthony Central Hospital
Denver, Colorado, United States
University of Colorado Cancer Center at University of Colorado Health Sciences Center
Denver, Colorado, United States
Montrose Memorial Hospital Cancer Center
Montrose, Colorado, United States
Start Date
December 1, 2003
Primary Completion Date
July 1, 2007
Completion Date
August 1, 2009
Last Updated
November 6, 2017
NCT06926283
NCT03050268
NCT07548177
NCT06422806
NCT07467772
NCT05969860
Lead Sponsor
SWOG Cancer Research Network
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions